The possibility that a person may die within the next few days or hours should be recognised and communicated clearly. Decisions should then be made and actions taken in accordance with the person’s needs and wishes. These should be regularly reviewed and decisions revised accordingly.
Sensitive communication should take place between healthcare professionals and the dying person, and those identified as important to them.
The dying person, and those identified as important to them, should be involved in decisions about treatment and care to the extent that the dying person wants.
The needs of families and others identified as important to the dying person should be actively explored, respected and met as far as possible.
An individual tailored plan of care should be agreed, coordinated and delivered with compassion.This includes support to eat and drink as long as they wish to do so, as well as symptom control and psychological, social and spiritual support to ensure their comfort and dignity.
Shifa4All is one of the best Pakistan’s Healthcare Service provider. Shifa4All has PMC verified Doctors with more than 20 years of International Health care experience in the fields of General/Internal Medicine, Geriatric Medicine, Frailty, Palliative, End of life care, Rehabilitation Medicine and family Medicine.
Experienced in the management of Dementia Patients, Stroke & Heart Diseases.
SKIN DISORDERS IN DARKER SKIN INDIVIDUALS-1
Common Skin Conditions for People of Color
Skin cancer. Melanoma is the third most common but most dangerous type of skin cancer.
Acne. Acne affects all races and genders and often starts in the early teens, but can reappear, particularly in women in their 30s and 40s.
Coronavirus-Symptoms & Prevention
The main symptoms of coronavirus (COVID-19) are: a high temperature – this means you feel hot to touch on your chest or back (you do not need to measure your temperature)a new, continuous cough – this means coughing a lot for more than an hour, or 3 or more coughing episodes in 24 hours (if you usually have a cough, it may be worse than usual)a loss or change to your sense of smell or taste – this means you've noticed you cannot smell or taste anything, or things smell or taste different to normal
Chronic obstructive pulmonary disease (COPD) is a chronic inflammatory lung disease that causes obstructed airflow from the lungs. Symptoms include breathing difficulty, cough, mucus (sputum) production and wheezing. It's typically caused by long-term exposure to irritating gases or particulate matter, most often from cigarette smoke. People with COPD are at increased risk of developing heart disease, lung cancer and a variety of other conditions.
Emphysema and chronic bronchitis are the two most common conditions that contribute to COPD. These two conditions usually occur together and can vary in severity among individuals with COPD.
Chronic bronchitis is inflammation of the lining of the bronchial tubes, which carry air to and from the air sacs (alveoli) of the lungs. It's characterized by daily cough and mucus (sputum) production.
Emphysema is a condition in which the alveoli at the end of the smallest air passages (bronchioles) of the lungs are destroyed as a result of damaging exposure to cigarette smoke and other irritating gases and particulate matter.
Although COPD is a progressive disease that gets worse over time, COPD is treatable. With proper management, most people with COPD can achieve good symptom control and quality of life, as well as reduced risk of other associated conditions.
Osteoporosis is a bone disease that occurs when the body loses too much bone, makes too little bone, or both. As a result, bones become weak and may break from a fall or, in serious cases, from sneezing or minor bumps. Osteoporosis means “porous bone.” Viewed under a microscope, healthy bone looks like a honeycomb.
This summary covers identifying, assessing, and managing the long-term effects of COVID-19, often described as ‘long COVID’. It makes recommendations for primary care about care for adults, children, and young people who have new or ongoing symptoms 4 weeks or more after the start of acute COVID-19